BioNexus Gene Lab Corp (BGLC) — Capital Expenditures
| Fiscal Year | Capital Expenditures | Change YoY |
|---|---|---|
| 2025 | $37.0K | -83.7% |
| 2024 | $227.0K | +51.9% |
| 2023 | $149.4K | — |
| 2022 | $0 | -100.0% |
| 2021 | $3.2K | -99.3% |
| 2020 | $421.6K | +3189.5% |
| 2019 | $12.8K | +132.3% |
| 2018 | -$39.6K | — |
| Fiscal Year | Capital Expenditures | Change YoY |
|---|---|---|
| 2025 | $37.0K | -83.7% |
| 2024 | $227.0K | +51.9% |
| 2023 | $149.4K | — |
| 2022 | $0 | -100.0% |
| 2021 | $3.2K | -99.3% |
| 2020 | $421.6K | +3189.5% |
| 2019 | $12.8K | +132.3% |
| 2018 | -$39.6K | — |